| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 45,415 | $70.41 | $3,197,684.33 | -4.1% | +58.6% | +78.5% | |
| Nov 18, 2024 | WGS Genedx Holdings Corp. | Icahn School Of Medicine At Mount Sinai | 10% Owner | Sell | 147,141 | $70.64 | $10,393,722.68 | -2.6% | +58.6% | +78.5% | |
| Nov 15, 2024 | CSTL Castle Biosciences Inc | Stokes Frank70 | Chief Financial Officer | Sell | 6,923 | $29.93 | $207,217.21 | -10.0% | -1.7% | +19.0% | |
| Nov 15, 2024 | NTRA Natera, Inc. | Baynes Roy D. | Director | Sell | 37,230 | $146.11 | $5,439,564.61 | -18.7% | +16.9% | +39.9% | |
| Nov 15, 2024 | NEO Neogenomics Inc | Olivo Alicia C69 | General Counsel | Sell | 5,175 | $15.36 | $79,475.06 | -12.2% | -7.5% | -31.2% | |
| Nov 15, 2024 | XGN Exagen Inc. | Black Jeffrey G.75 | Chief Financial Officer | Buy | 22,298 | $2.98 | $66,448.04 | +8.8% | +43.3% | +202.3% | |
| Nov 15, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 4,728 | $146.41 | $692,209.34 | -0.4% | +16.9% | +39.9% | |
| Nov 14, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.62 | $161,980.00 | - | +1.2% | -21.0% | |
| Nov 14, 2024 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 2,212 | $158.53 | $350,671.62 | -2.2% | +13.8% | +35.2% | |
| Nov 14, 2024 | XGN Exagen Inc. | Aballi John64 | President And CEO | Buy | 24,305 | $2.81 | $68,297.05 | +3.7% | +49.0% | +210.7% | |
| Nov 13, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 36,300 | $154.86 | $5,621,396.41 | -4.2% | +5.4% | +24.7% | |
| Nov 13, 2024 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Buy | 19,500 | $51.35 | $1,001,325.00 | +1.8% | +0.7% | +33.6% | |
| Nov 13, 2024 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 2,896 | $29.90 | $86,595.32 | -27.5% | +37.9% | +197.8% | |
| Nov 12, 2024 | GH Guardant Health, Inc. | Clark Ian T72 | Director | Sell | 8,318 | $29.45 | $244,929.50 | -25.6% | +49.3% | +229.1% | |
| Nov 12, 2024 | VCYT Veracyte, Inc. | Chambers Rebecca73 | Chief Financial Officer | Sell | 15,275 | $38.34 | $585,663.36 | -10.9% | +9.6% | +10.6% | |
| Nov 12, 2024 | VCYT Veracyte, Inc. | Epstein Robert S | Director | Sell | 15,000 | $38.32 | $574,830.00 | -25.2% | +9.6% | +10.6% | |
| Nov 12, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 5,127 | $34.15 | $175,087.05 | -2.0% | -15.5% | +6.2% | |
| Nov 12, 2024 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 427 | $1.40 | $595.96 | -0.2% | -32.1% | -71.6% | |
| Nov 12, 2024 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 203 | $1.40 | $283.32 | -0.9% | -32.1% | -71.6% | |
| Nov 12, 2024 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 462 | $1.40 | $644.81 | -0.2% | -32.1% | -71.6% | |
| Nov 12, 2024 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 971 | $1.40 | $1,355.23 | -0.2% | -32.1% | -71.6% | |
| Nov 12, 2024 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 3,740 | $1.40 | $5,219.91 | -0.3% | -32.1% | -71.6% | |
| Nov 11, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 1,507 | $48.00 | $72,332.99 | -1.6% | +2.9% | -33.8% | |
| Nov 11, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 1,347 | $48.00 | $64,653.31 | -1.2% | +2.9% | -33.8% | |
| Nov 11, 2024 | TWST Twist Bioscience Corp | Chess Robert84 | Director | Sell | 3,600 | $47.26 | $170,138.75 | -7.5% | +2.9% | -33.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.